Great Lakes Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Great Lakes Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-658,935	Closed	-$6.93M	–	799
2023 Q1	$6.93M	Sell	658,935 -38,977	-6%	-$437K	0.06%	292
2022 Q4	$8.65M	Sell	697,912 -15,893	-2%	-$180K	0.5%	27
2022 Q3	$7.39M	Sell	713,805 -22,843	-3%	-$259K	0.16%	164
2022 Q2	$8.49M	Sell	736,648 -11,039	-1%	-$130K	0.17%	157
2022 Q1	$9.41M	Sell	747,687 -186,368	-20%	-$2.14M	0.15%	171
2021 Q4	$10.9M	Sell	934,055 -20,953	-2%	-$257K	0.17%	169
2021 Q3	$12.5M	Sell	955,008 -30,897	-3%	-$399K	0.19%	153
2021 Q2	$12.7M	Buy	985,905 +8,732	+0.9%	+$100K	0.19%	162
2021 Q1	$10.9M	Buy	+977,173	New	+$10.3M	0.18%	176

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Great Lakes Advisors's IRWD Position: Q2 2023 in Review

Great Lakes Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 658,935 shares — an estimated $6.93M sold.

Great Lakes Advisors first reported a position in IRWD in Q1 2021 and held it in 9 quarters. The position peaked at $12.7M in Q2 2021. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

Great Lakes Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Great Lakes Advisors sold 658,935 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $6.93M.
Great Lakes Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 9 quarters.
Great Lakes Advisors's Ironwood Pharmaceuticals position peaked at $12.7M in Q2 2021.
252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Great Lakes Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.